ClinicalTrials.Veeva

Menu

A Comparative Analysis of Ultrasound's Accuracy in Diagnosing HC Using Histopathology as Gold Standard

S

Superior University

Status

Active, not recruiting

Conditions

Hepatocellular Carcinoma

Treatments

Radiation: Group 1

Study type

Observational

Funder types

Other

Identifiers

NCT06748755
MSAHS/Batch-Spring23/047

Details and patient eligibility

About

The study aims to evaluate the accuracy of ultrasound in diagnosing hepatocellular carcinoma (HCC), using histopathology as the gold standard. It addresses HCC's high global incidence and the utility of ultrasound as a non-invasive, cost-effective screening tool. Despite ultrasound's accessibility, its diagnostic limitations necessitate further investigation to improve clinical outcomes.

Enrollment

90 patients

Sex

All

Ages

18 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Clinically suspected liver cancer patients undergoing ultrasound examination.
  • Patients undergoing histopathological examination (liver biopsy or resection) for definitive diagnosis.

Exclusion criteria

  • Patients with history of liver cancer treatment or inadequate data."

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems